Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

Presspart Nemo, the new specialist injection moulding division of Presspart, has begun manufacturing a six-piece nasal drug delivery device for GlaxoSmithKline’s Avamys (fluticasone furoate), an intranasal corticosteroid treatment for allergic rhinitis. Presspart Nemo will be launching its joint capabilities at the Respiratory Drug Delivery exhibition in Lisbon, Portugal, 19-22 May 2009, for which Presspart is a Silver sponsor.

Presspart is the world’s leading provider of specialist metal and plastic components to the pharmaceutical industry, and Nemo SA develops precision plastic parts according to customer requirements. Bringing together the two companies’ complementary capabilities provides opportunities to offer novel solutions to the pharmaceutical industry.

The Avamys device is produced at the company’s facilities in Spain, where it recently introduced a lean manufacturing approach to reduce waste and energy consumption, while maintaining high standards of quality control.

“The Avamys device is a great example of Presspart Nemo’s injection-moulding know how,” said Ramón Marqués, Managing Director at Presspart Nemo. “We are planning a range of extensions to our product offerings for the future in continuing to expand Presspart Nemo’s capabilities.”

###

For more information, please contact Joanna Riley at Presspart on: +44(0)1254 582233, email joanna.riley@presspart.com or online at www.presspart.com

For editorial follow-up, please contact Kate Whelan at Gyro International on: +44 (0) 161 876 5522 or email kate.whelan@gyrointernational.com

MEDIA INFORMATION:

About Presspart

Presspart and Presspart Nemo specialise in high precision, metal and plastic components and drug delivery devices for the pharmaceutical industry. With over 35 years’ experience in supplying deep-drawn metal MDI canisters, MDI valve components, plastic actuators and new drug delivery devices, both divisions constantly study, refine and optimise their processes to ensure optimum quality and performance for customers. Presspart and Presspart Nemo are leading suppliers and partner to many of the world’s largest pharmaceutical producers.

This press release was distributed by ResponseSource Press Release Wire on behalf of Gyro: in the following categories: Health, Medical & Pharmaceutical, Manufacturing, Engineering & Energy, for more information visit https://pressreleasewire.responsesource.com/about.